Efforts Continue To Identify Ebola Therapies, Vaccines, Prevent Sales Of Fraudulent Products
News outlets report on efforts to develop Ebola vaccines and therapies and keep fraudulent products off the market.
Bloomberg TV: Meet the Ebola Virus Hunters Searching for a Cure
In a video, “Laurie Garrett, senior fellow for global health at the Council on Foreign Relations, and Scripps Research Institute’s Dr. Erica Ollmann Saphire discuss the first case of deadly Ebola diagnosed in the U.S. They speak with Pimm Fox on ‘Taking Stock’…” (10/1).
Huffington Post: Why We Won’t Have An Ebola Cure Or Vaccine For Years
“…The world has known about Ebola for almost 40 years, yet there’s no cure or vaccine on the market. That could change amid worldwide attention to the ongoing outbreak of the virus in West Africa, which has claimed more than 3,000 lives already, and the first diagnosis of a patient with the disease in the United States. But not for a few more years — at least…” (Young, 10/2).
Wall Street Journal: FDA Cracks Down on Sellers Touting Ebola Treatments
“The Food and Drug Administration is cracking down on sellers of so-called essential oils who are claiming on social media sites that their products prevent or cure Ebola. The actions are part of a broader effort by the regulatory agency to stop false claims that spread quickly via online social networks…” (Andrews, 10/2).
Washington Post: A Liberian doctor is using HIV drugs to treat Ebola victims. The NIH is intrigued.
“…Gorbee Logan, a doctor in rural Liberia, has given at least 15 Ebola patients lamivudine, which is considered a long-term and effective drug to treat HIV patients. All but two of them survived, Logan told CNN last week. Since that interview, Logan has been in contact with Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, about the treatment…” (Izadi, 10/2).